Trump's Initiative to Reevaluate Ibogaine Restrictions: A Turning Point for PTSD Treatment
Published on: April 18, 2026, 3:06 a.m. | Source: Devdiscourse
U.S. President Donald Trump is set to order a reevaluation of ibogaine, a psychedelic drug used for PTSD internationally but restricted in the U.S. As advocates push for easier access, recent studies point to its potential benefits for mental health conditions, despite possible side effects.
